BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 20637785)

  • 1. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
    Keov P; Sexton PM; Christopoulos A
    Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.
    Presland J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):567-76. PubMed ID: 16159018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
    Urwyler S
    Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of G-protein coupled receptors.
    Jensen AA; Spalding TA
    Eur J Pharm Sci; 2004 Mar; 21(4):407-20. PubMed ID: 14998571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.
    Leach K; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2007 Aug; 28(8):382-9. PubMed ID: 17629965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in G protein-coupled receptor allostery: from function to structure.
    Christopoulos A
    Mol Pharmacol; 2014 Nov; 86(5):463-78. PubMed ID: 25061106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.
    Valant C; Robert Lane J; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2012; 52():153-78. PubMed ID: 21910627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein-coupled receptor allosterism: the promise and the problem(s).
    Christopoulos A; May LT; Avlani VA; Sexton PM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging the gap: bitopic ligands of G-protein-coupled receptors.
    Lane JR; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2013 Jan; 34(1):59-66. PubMed ID: 23177916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
    Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: a critical assessment.
    Raddatz R; Schaffhauser H; Marino MJ
    Biochem Pharmacol; 2007 Aug; 74(3):383-91. PubMed ID: 17572390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox.
    Langmead CJ; Christopoulos A
    Trends Pharmacol Sci; 2006 Sep; 27(9):475-81. PubMed ID: 16889837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.